Publications by authors named "Jonathan Steinfeld"

Claim this Profile
M
Mepolizumab has clinical benefits including oral corticosteroid sparing irrespective of baseline EGPA characteristics.
David R W Jayne, Benjamin Terrier, Bernhard Hellmich, Paneez Khoury, Lee Baylis, Jonathan Steinfeld

ERJ Open Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Benefit of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis for Patients With and Without a Vasculitic Phenotype.
Benjamin Terrier, David R W Jayne, Bernhard Hellmich, Jane H Bentley, Jonathan Steinfeld

ACR Open Rheumatol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HES and EGPA: Two Sides of the Same Coin.
Paneez Khoury, Praveen Akuthota, Namhee Kwon, Jonathan Steinfeld, Florence Roufosse

Mayo Clin Proc· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome.
Florence Roufosse, Joseph Butterfield, Jonathan Steinfeld, Jane H Bentley, Robyn von Maltzahn

Front Med (Lausanne)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5.
Marc E Rothenberg, Florence Roufosse, Stanislas Faguer, Gerald J Gleich, Jonathan Steinfeld

J Allergy Clin Immunol Pract· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of disease flares and impact of mepolizumab in patients with hypereosinophilic syndrome.
Fabrizio Pane, Guillaume Lefevre, Namhee Kwon, Jane H Bentley, Steven W Yancey, Jonathan Steinfeld

Front Immunol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review.
Gema Requena, Judith van den Bosch, Praveen Akuthota, Anna Kovalszki, Jonathan Steinfeld

J Allergy Clin Immunol Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Baseline Therapy and Flare Reduction in Mepolizumab-Treated Patients With Hypereosinophilic Syndrome.
Andreas Reiter, Guillaume Lefevre, Maria C Cid, Namhee Kwon, Eleni Mavropolou, Jonathan Steinfeld

Front Immunol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.
Ian D Pavord, Elisabeth H Bel, Arnaud Bourdin, Robert Chan, Joseph K Han, Jonathan Steinfeld

Allergy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom.
Gema Requena, John Logie, Daniel C Gibbons, Jonathan Steinfeld, Melissa K Van Dyke

Immun Inflamm Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Mepolizumab in Hypereosinophilic Syndrome: An Open-Label Extension Study.
Gerald J Gleich, Florence Roufosse, Geoffrey Chupp, Stanislas Faguer, Bastian Walz, Jonathan Steinfeld

J Allergy Clin Immunol Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Justification of the Subcutaneous Mepolizumab Dose of 300 mg in Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome.
Isabelle J Pouliquen, Daren Austin, Jonathan Steinfeld, Steven W Yancey

Clin Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Eosinophilic Granulomatosis With Polyangiitis and Associated Health Care Utilization Among Patients With Concomitant Asthma in US Commercial Claims Database.
Mugdha Gokhale, Christopher F Bell, Scott Doyle, Jolyon Fairburn-Beech, Jonathan Steinfeld

J Clin Rheumatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to a case report: Idiopathic hypereosinophilic syndrome in remission with benralizumab treatment after relapse with mepolizumab.
Gema Requena, Florence Roufosse, Lee D Baylis, Jonathan Steinfeld

Respirol Case Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial.
Florence Roufosse, Jean-Emmanuel Kahn, Marc E Rothenberg, Andrew J Wardlaw, Amy D Klion, Jonathan Steinfeld

J Allergy Clin Immunol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool.
Nicholas Kovacs, Katy Benjamin, Nicole Holland-Thomas, Olga Moshkovich, Linda M Nelsen, Jonathan Steinfeld

J Allergy Clin Immunol Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis.
Lynn D Condreay, Laura R Parham, Xiaoyan A Qu, Jonathan Steinfeld, Michael E Wechsler

Rheumatol Int· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma.
Atul Gupta, Isabelle Pouliquen, Daren Austin, Robert G Price, Rodger Kempsford, Jonathan Steinfeld

Pediatr Pulmonol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome.
Fei Li Kuang, Michael P Fay, JeanAnne Ware, Lauren Wetzler, Nicole Holland-Thomas, Jonathan Steinfeld

J Allergy Clin Immunol Pract· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and pharmacodynamics of mepolizumab in children with severe asthma with an eosinophilic phenotype.
Atul Gupta, Masanori Ikeda, Bob Geng, Jay Azmi, Robert G Price, Jonathan Steinfeld

J Allergy Clin Immunol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Michael E Wechsler, Isabelle Pouliquen, Jonathan Steinfeld, Eric S Bradford,

J Allergy Clin Immunol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Jonathan Steinfeld, Eric S Bradford, Judith Brown, Stephen Mallett, Steven W Yancey

J Allergy Clin Immunol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).
Paneez Khoury, Praveen Akuthota, Steven J Ackerman, Joseph R Arron, Bruce S Bochner, Jonathan Steinfeld

J Leukoc Biol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, efficacy, and dose response of fluticasone propionate delivered via the novel MDPI in patients with severe asthma: A randomized, controlled, dose-ranging study.
David I Bernstein, Michael Gillespie, Sharon Song, Jonathan Steinfeld

J Asthma· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Michael E Wechsler, Praveen Akuthota, David Jayne, Paneez Khoury, Amy Klion, Jonathan Steinfeld

N Engl J Med· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis